Enzymatica publ AB
Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Enzymatica publ AB (ENZY) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.085x
Based on the latest financial reports, Enzymatica publ AB (ENZY) has a cash flow conversion efficiency ratio of -0.085x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.57 Million) by net assets (Skr135.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Enzymatica publ AB - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Enzymatica publ AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Enzymatica publ AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Enzymatica publ AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kindly MD, Inc. Common Stock
NASDAQ:KDLY
|
-0.310x |
|
WITTED MEGACORP OYJ EO 1
F:8OS
|
N/A |
|
Munjal Auto Industries Limited
NSE:MUNJALAU
|
-0.040x |
|
Enogia SAS
PA:ALENO
|
-0.051x |
|
Uni Charm Indonesia PT
JK:UCID
|
0.014x |
|
Guyoung Technology Co. Ltd
KQ:053270
|
0.066x |
|
PJ Electronics Co. Ltd
KQ:006140
|
0.084x |
|
Chengdu PUTIAN Telecommunications Cable Company Limited
F:CUEH
|
-0.029x |
Annual Cash Flow Conversion Efficiency for Enzymatica publ AB (2009–2024)
The table below shows the annual cash flow conversion efficiency of Enzymatica publ AB from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr176.37 Million | Skr-60.51 Million | -0.343x | +34.76% |
| 2023-12-31 | Skr76.61 Million | Skr-40.29 Million | -0.526x | -2.86% |
| 2022-12-31 | Skr126.29 Million | Skr-64.57 Million | -0.511x | -78.12% |
| 2021-12-31 | Skr124.97 Million | Skr-35.87 Million | -0.287x | -187.36% |
| 2020-12-31 | Skr106.65 Million | Skr-10.65 Million | -0.100x | +68.32% |
| 2019-12-31 | Skr119.20 Million | Skr-37.58 Million | -0.315x | -74.80% |
| 2018-12-31 | Skr159.66 Million | Skr-28.79 Million | -0.180x | +11.46% |
| 2017-12-31 | Skr110.70 Million | Skr-22.55 Million | -0.204x | +24.73% |
| 2016-12-31 | Skr142.04 Million | Skr-38.43 Million | -0.271x | +84.20% |
| 2015-12-31 | Skr21.98 Million | Skr-37.65 Million | -1.712x | -162.87% |
| 2014-12-31 | Skr62.42 Million | Skr-40.67 Million | -0.651x | +44.40% |
| 2013-12-31 | Skr15.73 Million | Skr-18.43 Million | -1.172x | -127.13% |
| 2012-12-31 | Skr14.06 Million | Skr-7.25 Million | -0.516x | +64.79% |
| 2011-12-31 | Skr3.31 Million | Skr-4.86 Million | -1.465x | -1395.19% |
| 2009-12-31 | Skr-901.48K | Skr-101.99K | 0.113x | -- |